Aggregation of childhood leukemia in geographic areas of Greece)
Authors
Eleni Petridou Freda E. Alexander Dimitrios Trichopoulos Katharine Revinthi Nick Dessypris Naomi Wray Stavros Haidas Dimitrios Koliouskas Helen Kosmidis Fani Piperopoulou Fotini Tzortzatou
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.